BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21306847)

  • 1. Usefulness of US-CT 3D dual imaging for the planning and monitoring of hepatocellular carcinoma treatment using HIFU.
    Fukuda H; Numata K; Nozaki A; Morimoto M; Kondo M; Tanaka K; Maeda S; Yamagata J; Ohto M; Ito R; Sakamoto A; Zhu H; Wang ZB
    Eur J Radiol; 2011 Dec; 80(3):e306-10. PubMed ID: 21306847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US-CT 3D dual imaging by mutual display of the same sections for depicting minor changes in hepatocellular carcinoma.
    Fukuda H; Ito R; Ohto M; Sakamoto A; Otsuka M; Togawa A; Miyazaki M; Yamagata H
    Eur J Radiol; 2012 Sep; 81(9):2014-9. PubMed ID: 21676568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
    Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
    Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.
    Zhu H; Zhou K; Zhang L; Jin C; Peng S; Yang W; Li K; Su H; Chen W; Bai J; Wu F; Wang Z
    Eur J Radiol; 2009 Oct; 72(1):160-6. PubMed ID: 18707834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Findings of multidetector row computed tomography of HCCs treated by HIFU ablation.
    Fukuda H; Numata K; Nozaki A; Morimoto M; Kondo M; Tanaka K; Maeda S; Ohto M; Ito R; Zhu H; Wang ZB
    Eur J Radiol; 2012 Mar; 81(3):e239-43. PubMed ID: 21339057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas.
    Fukuda H; Numata K; Nozaki A; Kondo M; Morimoto M; Maeda S; Tanaka K; Ohto M; Ito R; Ishibashi Y; Oshima N; Ito A; Zhu H; Wang ZB
    Abdom Imaging; 2013 Dec; 38(6):1263-8. PubMed ID: 23728304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.
    Xu G; Luo G; He L; Li J; Shan H; Zhang R; Li Y; Gao X; Lin S; Wang G
    Ultrasound Med Biol; 2011 Dec; 37(12):1993-9. PubMed ID: 22036638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system.
    Kudo K; Moriyasu F; Mine Y; Miyata Y; Sugimoto K; Metoki R; Kamamoto H; Suzuki S; Shimizu M; Miyahara T; Yokoi M; Horibe T; Yamagata H
    Eur J Radiol; 2007 Feb; 61(2):324-31. PubMed ID: 17049791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
    Jin C; Zhu H; Wang Z; Wu F; Chen W; Li K; Su H; Zhou K; Gong W
    Eur J Radiol; 2011 Dec; 80(3):662-9. PubMed ID: 20864286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
    Li YY; Sha WH; Zhou YJ; Nie YQ
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
    Minami Y; Chung H; Kudo M; Kitai S; Takahashi S; Inoue T; Ueshima K; Shiozaki H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances of imaging for hepatocellular carcinoma.
    Choi BI
    Oncology; 2010 Jul; 78 Suppl 1():46-52. PubMed ID: 20616584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
    Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
    Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic navigation in ultrasound-guided interventional radiology procedures.
    Xu HX; Lu MD; Liu LN; Guo LH
    Clin Radiol; 2012 May; 67(5):447-54. PubMed ID: 22153232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of clinical application of high intensity focused ultrasound in non-invasive therapy for liver cancer].
    Yi J; Li N; Jiang LS; Xiong XZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):426-8. PubMed ID: 15931887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.